<DOC>
	<DOCNO>NCT01542008</DOCNO>
	<brief_summary>Bipolar disorder ( BD ) serious chronic mental illness associate substantial impairment quality life functional outcome , high rate suicide , high financial cost . In spite proliferation treatment BD , nearly half individual BD benefit pharmacotherapy sub-optimal medication treatment adherence . Non-adherence BD medication treatment dramatically worsen outcome . Reasons non-adherence among individual BD multi-dimensional , suggest adherence enhancement might work best intervention specifically address factor important modifiable specific individual . In spite enormity problem , literature intervention improve treatment adherence surprisingly limited . There urgent need intervention enhance treatment adherence among BD patient : 1 ) high risk future treatment non-adherence ; 2 ) may access interest long-term , high-intensity , specialize care ; 3 ) flexible patient-focused take account reason non-adherence specific individual . The propose study first-ever RCT focus specifically BD treatment adherence enhancement , test whether customized adherence enhancement ( CAE ) psychosocial intervention improve adherence mental health outcome compare broadly-directed , non-individualized education ( EDU ) . The propose project potential greatly advance care BD patient great risk poor health outcome , finding expect generalizable across variety treatment setting . Hypothesis 1 : CAE associate great improvement treatment adherence compare broadly-directed , non-individualized BD education ( EDU ) . Hypothesis 2 : CAE associate improved BD symptom compare EDU .</brief_summary>
	<brief_title>Treatment Adherence Enhancement Bipolar Disorder</brief_title>
	<detailed_description />
	<mesh_term>Disease</mesh_term>
	<mesh_term>Bipolar Disorder</mesh_term>
	<criteria>Subjects must type I type II Bipolar Disorder ( BD ) confirm Structured Clinical Interview DSMIV Axis I Disorders Patient Version ( SCIDP ) Have BD least two year duration Have receive treatment least one evidencebased medication stabilize mood least six month ( lithium , anticonvulsant , antipsychotic mood stabilizer ) Either 20 % nonadherent current BD medication treatment ( i.e . lithium , anticonvulsant , antipsychotic mood stabilizer ) Unable unwilling participate psychiatric interview . This include individual , may psychotic participate interviews/rating scale Unable unwilling give write , inform consent study participation Individuals high risk suicide safely manage current treatment setting</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>